To study the interactions between chemical carcinogens and oncogenic retroviruses, BALB/Mo mice which carry the Moloney murine leukemia virus (M-MuLV) as an endogenous virus, and conventional (M-MuLV-free) BALB/c mice, as well as their Bcl (M-MuLV+ or M-MuLV-) hybrids were injected neonatally with a single dose of urethane. BALB/Mo and V+ Bcl mice showed accelerated lymphoma development; similar results were obtained in BALB/Mo mice receiving one or two doses of urethane transplacentally. Lung adenomas developed with shorter latency and higher incidence in BALB/Mo mice given urethane a t birth; however, significant differences in the incidence of lung adenomas in BALB/Mo mice were found only in two experiments.
INTRODUCTION
viral gene expression and amplification lYmPllomas, mostly derived from T lymphocytes (13) . The advantages offered by this system are the following: (a) the animals are virus-infectcd without manipulation; (b) although devoid of a transforming gene, M-MuLV is oncogenic per se and, at least before its amplification, may be considered as a pure c h e d virus; (c) appropriate M-MuLV-free controls with similar genetic background, e.g.9 BALB/c mice, are readily available. Using the sister chromatid exchange (SCE) assay we found that BALB/Mo lymphocytes,' compared BALB/c controls, show a higher base line frequency of SCE and are far more susceptible to SCE induction by mitomycin c p uretllane, and potassium &chromate (5, Despite extensive investigation there is still within target tissues, BALB/Mo mice develop no clear indication of the mechanisms responsible for the synergistic effect usually observed betiveen viruses and chemical carcinogens in tumor induction. Mre have been studying interactions between Moloney murine leukemia virus (M-M~L V ) and different chemical compounds in BALB/Mo mice which carry the M -M~L V proviral sequences integrated at a single loc u~ (Mov-1) into germ line and, consequently. in every somatic cell. Following Presented at the Second International Symposium sponsored by the Universities of Sassari and Cagliary, Session 111: "hletabolism of Chemical Carcinogens and Sequential Analysis." October 12-15. 1983. Alghero. Italy. This Symposium section computes the seriesof papers published in Volume 12,
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CHIECO-BIANCHI ET AL TOXICOLOGIC PATHOLOGY induced by urethane evaluated by the micronucleus assay on bone marrow polychromatic erythrocytes is more pronounced in BALB/Mo than in BALB/c cells (1) . In this paper we report long-term results in BALB/Mo and BALB/c mice treated with urethane at perinatal age. Furthermore, preliminary data on the effects of a viral inhibitor on SCE induction are presented.
MATERIALS AND METtiODS
BAI,B/Mo mice were originally obtained through the courtesy of Dr. R. Jaenisch, of the Heinrich-Pette Institute for Experimental Virology and Immunology, University of Hamburg, FRG. Control BALB/c mice were originally purchased from the Jackson Laboratory, Bar Harbor, MN. The animals were maintained by brother x sister inbreeding in plastic cages in temperature-controlled rooms (21-24°C) and fed a standard mouse diet (Piccioni, Brescia) with free access to water.
Urethane Carcinogenesis
Neonatal Treatment. Newborn mice, less than 48 hr old, were injected subcutaneously in the interscapular region with a single dose of 1 mg of urethane (Carlo Erba, Milano) in 0.10 ml of physiologic saline. They were killed at 2, 4, 6, and 8 months of age.
Transpfacentaf Treatment. Pregnant females were injected S.C. in the inguinal region with one or two doses of 35 mg of urethane in 0.35 ml of physiologic saline (approximately 1 mg/g of body weight) on day 3 or days 3 and 1, respectively, before delivery; offspring were killed at 2 , 4 , 6, and 8 months of age. Older age groups were not studied because of the high incidence of deaths due to "spontaneous" lymphomas which occur in untreated BALB/Mo mice (see also Fig. 1 ). Some mice receiving neonatal or transplacental urethane treatment died spontaneously or were killed when moribund between death intervals; these were assigned to the nearest experimental group according to the time of death.
All animals underwent complete autopsy. Tumors and all lesions that were suspect for neoplasia were excised and processed for histologic examination. The number of pulmonary tumors was determined by counting surface nodules detected on gross inspection of the lungs. All lung tumors in urethanetreated animals were classified histologically as adenomas (alveologenic carcinoma accord-ing to Stewart et a1 (22) ). Lymphomas in untreated and experimental animals were, in the great majority of cases, thymic lymphosarcomas with or without involvement of spleen, lymph nodes, and other organs (9).
For statistical analysis, the association x square was calculated following Cochran's method as described by Fleiss (12) .
Short-term Studies on SCE Induction
Cell suspensions obtained from 2-monthold BALB/Mo and BALB/c donors were prepared as already reported (17) , and incubated for 68 hr at 37°C in a 5% CO, atmosphere. Concanavalin A (5 pg/ml, Con A, Pharmacia, Uppsala, Sweden), and bromodeoxyuridine ( 4 hr, colchicine (0.4 mg/ml, Merck, Darmstad, FRG) was added, and SCE were detected on chromosome preparations obtained from 2nd generation metaphase cells by staining with Giemsa following the procedures already described (17) .
Virus production was determined on end culture supernatants by the UV/XC cell plaque assay (21) as reported in Ref. 7 . For statistical analysis, the classical x square test was used (12) .
RESULTS

Long-term studies on Urethane-induced Carcinogenesis
Neonatal Treatment. The results of the first experiments are summarized in Table I . Since no sex differences were observed in these as well as in the other experiments, data concerning male and female animals have been pooled. Urethane injection in newborn BALB/Mo and BALB/c mice induced lung adenomas and lymphomas with an incidence that increased progressively with the age at death. A total of 34 and 15 out of 40 BALB/Mo mice developed lung adenomas and lymphomas, respectively. In the control group, a total of 18 and 4 out of 31 BALB/c mice had lung adenomas and lymphomas, respectively. Thus, the final incidence of both types of tumor was significantly higher ( p < Mice were injected S.C. with 1 mg of urethane in 0.10 ml of saline within 48 hr of birth. The mean number of lung adenomas per mouse is given in parentheses.
0.05), and the time of tumor appearance shorter in BALB/Mo than in BALB/c mice.
On the other hand, the mean number of lung adenomas per mouse was almost similar in mice of both strains. No other neoplastic Iesion was detected either in experimental or control groups. As already stated, untreated BALB/Mo mice develop lymphomas in high incidence, reaching 70% at 12 months of age; however, the latent period of lymphoma appearance is prolonged, as shown by the cumulative incidence ( Fig. 1 ). Therefore, urethane treatment is effective in considerably accelerating lymphoma development. It should also be added that the incidence of lung adenomas in BALB/Mo and BALB/c mice and of lymphomas in BALB/c untreated mice is less than 1% at the age of 10 months.
In order to further confirm the possible influence of M-MuLV on urethane carcinogenesis, 1st generation back cross (Bcl) mice were produced by mating BALB/c females with (BALB/c X BALB/Mo) F1 males. Since the parental BALB/Mo mice are homozygous regarding the Mov-1 locus (integrated M-MuLV proviral DNA), 50% of Bcl hybrids should segregate for M-MuLV+ according to Mendelian expectations. Bcl mice of the same litters were then injected S.C. with 1 mg of urethane when less than 48 hr old. At weaning (4 to 5 weeks of age), the mice were typed for M-MuLV positivity by tail biopsy using the UV/XC cell plaque assay. They were then killed at 4, 6, and 8 months of age. Table I1 presents the results of this experiment. The final percentage of lung adenomas was 87% in V+, and 63%in V-Bcl mice; this difference is not statistically significant (p > 0.10). On the other hand, the total incidence of lymphomas was significantly higher in V+ (13 out of 23 mice, 57%) than in V-Bcl mice (4 out of 19, 21%; p < 0.05). Moreover, as in the previous experiment, an accelerated appearance of lymphomas in V+ mice was evident when latency was compared to that seen in untreated V+ Bcl hybrids. Thus, even in a stringently similar genetic host background, M-MuLV appears to facilitate lymphoma development following urethane treatment.
Transplacental Treatment. As shown in Table 111, urethane administered transplacentally in BALB/Mo and BALB/c mice produced a tumor pattern essentially similar to that found in previous experiments, and oiily lung adenomas and lymphomas were detected during the 8-month observation period; tumorigenic activity was moderately less efficient than that observed following neonatal injection, even in offspring of mothers receiving 2 doses of urethane. Again, the incidence of lung adenomas was higher in BALB/Mo than in BALB/c mice at both dose levels, but the difference was significant only in offspring of mothers treated twice (p < 0.05).
Lymphomas were not found in BALB/c mice, whereas their total incidence in BALB/ Mo mice was 18% ( p < 0.005) and 42% ( p < 0.001) in animals receiving one or two ure- ' Mice were injected S.C. with 1 mg of urethane in 0.10 ml of saline within 48 hr of birth.
'The mean number of lung adenomas per mouse is given in parentheses.
thane doses, respectively. In addition, the cumulative lymphoma incidence observed in both groups of the BALB/Mo mice indicates a n accelerating effect when data (not shown in Fig. 1) are compared with those of untreated BALB/Mo controls.
In conclusion, it is evident that perinatal treatment with urethane increases the SUS-VOI. 12 Table V) . However, since the BUdR treatment necessary to visualize SCE also causes a ready inducibility of retroviruses (14) , it remained to be determined whether the integration of M-MuLV per se, or its expression, was responsible for SCE increase in M-MuLV-infected lymphocytes. Consequently, experiments were programmed to study the effects of substances known to inhibit the various steps of retrovirus life cycle. Cordycepin (3-deoxyadenosine), which blocks RNA maturation and viral assembly (ZO), was first investigated. In fact. as reported in Table IV , supernatants of Con A-stimulated UALB/Mo lymphocytes cultured in the presence of cordycepin contained less virus, and the reduction in virus titer (44.7%) was more pronounccd in BUdRtreated cultures. The effect of cordycepin on SCE frequency was then assayed. Table V shows that while cordycepin alone did not affect the number of SCE in BALB/c lympho- 
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DISCUSSION
It has long been known that fetal and neonatal periods of life are highly susceptible to chemical carcinogenesis, and indeed theoretical and practical proposals to incorporate perinatal exposure into routine toxicology assays for carcinogen detection have been presented (6) . The main reasons for this particular sensitivity are (a) the enzymatic activity, which becomes fully expressed only a few days after parturition, may slow down the metabolic inactivation of carcinogens, (b) the high number of structurally and functionally immature cells may provide a n extra amount of critical targets for Carcinogenic stimuli, and (c) the still poorly developed immune system may facilitate tumor development and progression through an inefficient surveillance mechanisms.
Urethane was one of the first chemicals to undergo extensive investigation for its transplacental and neonatal carcinogenic activity, and an increased tumorigenic response was observed, especially for lung, liver, skin, and lymphoid organs, (3, 8, 10) . It was also demonstrated that urethane injected into new-born mice is elminated at only a tenth of the adult rate and that the long retention time is due to the lack of liver esterase which metabolize urethane to CO, (18) . Moreover, the thymus and other lymphopoietic organs are dramatically affected by urethane treatment (11) as are different parameters of immune function (15, 19) .
In the present studies, urethane perinatal carcinogenesis was utilized to investigate interactions between chemical Carcinogens and retroviruses. The slow transforming leukemogenic M-MuLV, carried as an endogenous virus on the BALB/c genetic background, was the viral companion for the chemical. Both neonatal and transplacental urethane treatments induced accelerated lymphoma appearance in BALB/Mo (v+/v+) and in Bcl mice segregating for M-MuLV positivity (v+/ -), thus confirming previous data on the synergistic leukemogenic effect exerted by the drug and MuLV (4). However, the results on lung tumor induction were less clear, because a significant difference between BALB/ Mo and BALB/c animals was observed only in two experiments.
No other tumors, and particularly no hepatomas, were detected in urethane-treated mice; this could be due either to the relative short observation periods in relation to the more prolonged latency required for liver tumor appearance (31, or to the relatively low susceptibility of BALB/c mice to develop hepatomas (23). In any case, from the present results it appears that the synergistic tumorigenic effect involves preferentially the lymphatic tissue, which is a target specific for M- 367 MuLV-induced neoplastic transformation. The sole fact that the M-MuLV provirus is carried in every somatic cell is perhaps not sufficient to confer a higher sensitivity to carcinogenic stimuli, and other events such as expression of viral genes or integration of multiple viral copies through repeated cell infection cycles are probably required.
This possibility is also supported by the finding that cordycepin treatment reduced SCE frequency in M-MuLV-infected lymphocytes. As reported by Price et a1 (20), this antiviral antibiotic is able to inhibit induction by 5-iodo-2'-deoxyuridine of endogenous retrovirus by interfering with poly(A) synthesis. In the present experiments, which attempted to elucidate the synergism between M-MuLV and chemical carcinogens observed in the induction of short-term mutagenic effects (1, 5, 16, 17) , we found that incubation of BALB/Mo spleen lymphocytes in the presence of cordycepin produced a reduction in both M-MuLV yield and SCE frequency and that the decrease was even more marked after MMC treatment. Since no variation in SCE values was evident in both untreated and MMC-treated BALB/c lymphocytes after cordycepin incubation, it may be concluded that this SCE reducing effect is peculiar to BALU/Mo lymphocytes and most likely depends upon a reduction in virus synthesis. Although other experiments are programmed to investigate whether "normalization" of SCE values correlates with inhibition at other specific steps in the M-MuLV life cycle, these preliminary findings indicate that the mutagenicity-enhancing capacity of M-MuLV may well fit in with the idea that retroviruses act as insertional mutagens by interrupting or activating host cell genes (2) . In our assay system, however, proviral integration in a single copy into the cell DNA does not seem sufficient per se to bring about detectable genetic effects for the induction of which viral expression seems to play a more crucial role.
